Tbilisi, Georgia, 31 May 2023 - Recently, Shanghai MicroPort EP MedTech Co., Ltd. (referred to as "MicroPort EP") participated in the Silk Road Heart Rhythm Society Arrhythmia Congress jointly organized by the American Hospital Tbilisi and Dr. Roin Rekvava, Chairman of the Silk Road Heart Rhythm Society.
MicroPort EP showcased its relevant electrophysiology product solutions through a combination of booth exhibition and academic symposium. Dr. Jose Luis Merino, President of the European Heart Rhythm Association, delivered the opening speech at the conference, which was attended by over 400 electrophysiology experts and representatives from more than 10 countries.
During the academic symposium themed "Meet the Masters," Prof. Osman Can Yontar presented a session titled "Complex Ablation Cases with Columbus™ 3D EP Navigation System." Several exciting cases and experiences with the Columbus™ system garnered great attention and interest from the live audience. Additionally, the academic conference provided an online livestreaming channel, allowing viewers to experience the event remotely.
MicroPort EP also showcased comprehensive electrophysiology solutions through interactive booth displays, attracting electrophysiology experts from multiple countries, including Belarus, Georgia, Germany, Kazakhstan, Mongolia, Saudi Arabia, Spain, Turkey, and the United Arab Emirates. Visiting doctors highly praised the user-friendly interface and ease of operation of the Columbus™ 3D EP Navigation System V3, as well as its successful application in several complex cases. They also actively tried products from the EasyFinder®, EasyLoop®, and FireMagic® series. Dr. Jose Luis Merino and Dr. Roin Rekvava from American Hospital Tbilisi in Georgia visited the booth and exchanged in-depth views on the latest electrophysiology products and applications.
To date, MicroPort EP products have been exported to more than 30 countries and regions. In the future, MicroPort EP will continue to build a differentiated product portfolio and expand its global reach, offering comprehensive solutions for diagnosis and therapy of electrophysiology interventions to more patients and physicians worldwide.
About MicroPort EP
Founded in Shanghai in 2010, Shanghai MicroPort EP MedTech Co., Ltd. (“MicroPort EP”, stock code: 688351.SH), a joint-stock subsidiary of MicroPort Scientific Corporation (“MicroPort®”, stock code: 00853.HK), is a global medical devices company focusing on the development, manufacturing, and marketing of minimally invasive medical devices for the treatment of cardiac arrhythmia disease. It has developed a family of advanced cardiac ablation catheters, diagnostic catheters, and 3D navigation systems. These products are used by hundreds of physicians at over 600 hospitals across China and beyond. At MicroPort EP, we strive to provide integrated therapeutic solutions to apply precise navigation on interventional procedures, dedicated to providing high quality therapeutic solutions to patients and physicians across the globe.
More information is available at www.everpace.com.